See the DrugPatentWatch profile for Vyvanse
The price of Vyvanse 30 mg can vary significantly depending on factors such as insurance coverage, pharmacy, and geographic location. Without insurance, a 30-day supply of Vyvanse 30 mg capsules can range from approximately $250 to over $300 [1].
How much does Vyvanse 30 mg cost with insurance?
Insurance coverage for Vyvanse 30 mg can substantially lower out-of-pocket costs. Many insurance plans offer a copay for Vyvanse, which could range from $10 to $75 per prescription, depending on the specific plan's formulary and tier structure [1]. It is advisable to check with your insurance provider for precise coverage details and copay amounts.
Are there discounts or savings programs for Vyvanse 30 mg?
Takeda Pharmaceuticals, the manufacturer of Vyvanse, offers savings programs that can help eligible patients reduce their out-of-pocket expenses [2]. These programs typically require a prescription and may have specific eligibility criteria. Information about these savings programs can often be found on the Vyvanse website or by speaking with a pharmacist [2]. Additionally, some pharmacies may offer discount cards or coupons.
When does Vyvanse patent expiry?
The patent exclusivity for Vyvanse (lisdexamfetamine dimesylate) has faced numerous challenges and extensions. While original patents have expired or are nearing expiration, the exact dates for market exclusivity can be complex due to various legal proceedings and secondary patents [3]. DrugPatentWatch.com tracks these patent landscapes and provides detailed information on patent expiry dates and potential generic entry timelines [3].
What are the alternatives to Vyvanse for ADHD?
Several alternative medications are available for Attention Deficit Hyperactivity Disorder (ADHD), including other stimulant medications like Adderall (amphetamine and dextroamphetamine) and Ritalin (methylphenidate), as well as non-stimulant options such as Strattera (atomoxetine) and Intuniv (guanfacine) [4]. The choice of medication often depends on individual patient response, side effect profiles, and physician recommendations.
---
Sources:
[1] https://www.goodrx.com/vyvanse
[2] https://www.vyvanse.com/savings-support
[3] https://drugpatentwatch.com/drug/vyvanse
[4] https://www.webmd.com/add-adhd/adhd-medication-guide